Huan Ngoc Phan
Ophthalmology · Cupertino
- Medicare standing
- 2 flags on the record
- Listed below.
- Plans that list them
- 1
- 1 carrier
- Office
- 1
On the public record
- California licence: Current
- 1 Medical Board action on record
Offices
1 location
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Huan Ngoc Phan’s office at (408) 296-0100 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence G77619 · Current
Licensed to practise in California · since 1993 · expires 2027-01-31 · University of California, Davis School of Medicine. Board flags: Hospital Discipline Per B&P Cde Sect 805.
Public record actions
| 1994-07-18 | Hospital disciplineDiscipline | Termination or revocation of staff privileges · Kaiser foundation hospitalsanta clara, CA |
Original Medicare doctor bills
$1,671
Medicare paid this office $1,671 for 16 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Established patient complete exam of visual system | 12 | $1,231 | $103 |
Who their Medicare patients are
16 Original Medicare patients in 2024. Average age 76 · Health risk score 0.92. At or below the middle of the specialty; the typical ophthalmology clinician is at 1.16.
Conditions among them: High blood pressure 69%.
The office billed $3,585, Medicare allowed $2,512 and paid $1,671; for 19 services of 6 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 16 | 19 | 76 | 0.92 | $3,585 | $1,671 |
| 2023 | 27 | 41 | 77 | 0.70 | $7,510 | $3,656 |
| 2022 | 20 | 25 | 75 | 0.93 | $4,690 | $2,660 |
| 2021 | 21 | 37 | 78 | 0.80 | $7,640 | $3,622 |
| 2020 | 17 | 25 | 78 | 1.10 | $6,130 | $2,553 |
| 2019 | 97 | 209 | 78 | 1.06 | $37,350 | $16,551 |
| 2018 | 157 | 316 | 79 | 1.00 | $57,315 | $23,746 |
| 2017 | 156 | 345 | 78 | 1.16 | $53,505 | $23,984 |
| 2016 | 195 | 464 | 79 | 1.05 | $72,056 | $36,477 |
| 2015 | 235 | 631 | 78 | 1.10 | $95,470 | $43,110 |
| 2014 | 243 | 631 | 78 | 0.99 | $97,551 | $43,509 |
| 2013 | 236 | 619 | 78 | 1.06 | $81,635 | $36,192 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 1 service
| Established patient complete exam of visual system | 23 | $2,531 | $110 |
2022: 1 service
| Established patient complete exam of visual system | 13 | $1,577 | $121 |
2021: 1 service
| Established patient complete exam of visual system | 17 | $1,936 | $114 |
2019: 4 services
| Established patient complete exam of visual system | 81 | $8,583 | $105 |
| Established patient problem focused exam of visual system | 42 | $4,003 | $76 |
| Imaging of optic nerve | 19 | $641 | $32 |
| Examination of eye by ophthalmoscope with retinal drawing | 12 | $316 | $24 |
2018: 5 services
| Established patient complete exam of visual system | 98 | $9,669 | $95 |
| Established patient problem focused exam of visual system | 73 | $6,239 | $67 |
| New patient complete exam of visual system | 32 | $3,595 | $112 |
| Imaging of optic nerve | 18 | $484 | $27 |
| Examination of eye by ophthalmoscope with retinal drawing | 16 | $376 | $23 |
2017: 6 services
| Established patient problem focused exam of visual system | 77 | $8,965 | $65 |
| Established patient complete exam of visual system | 78 | $6,795 | $84 |
| New patient complete exam of visual system | 36 | $3,754 | $104 |
| Exam of visual field with extended testing | 13 | $689 | $53 |
| Imaging of optic nerve | 17 | $443 | $26 |
| Examination of eye by ophthalmoscope with retinal drawing | 20 | $389 | $19 |
2016: 7 services
| Established patient complete exam of visual system | 111 | $11,766 | $102 |
| Established patient problem focused exam of visual system | 111 | $11,206 | $72 |
| New patient complete exam of visual system | 38 | $4,803 | $126 |
| Exam of visual field with extended testing | 36 | $2,111 | $59 |
| Removal of eyelashes using forceps | 22 | $1,719 | $43 |
| Examination of eye by ophthalmoscope with retinal drawing | 25 | $582 | $21 |
| Exam of the internal drainage system of eye | 12 | $232 | $19 |
2015: 11 services
| Short return visit (20+ min) | 105 | $7,750 | $49 |
| Established patient complete exam of visual system | 67 | $6,721 | $100 |
| Established patient problem focused exam of visual system | 60 | $5,431 | $74 |
| Return visit (30+ min) | 80 | $5,417 | $62 |
| New patient complete exam of visual system | 37 | $4,245 | $115 |
| Exam of visual field with extended testing | 63 | $3,700 | $54 |
| Removal of eyelashes using forceps | 21 | $1,827 | $47 |
| New patient visit (45+ min) | 15 | $1,665 | $111 |
| Incision and drainage of cyst of eye | 11 | $1,371 | $105 |
| Examination of eye by ophthalmoscope with retinal drawing | 27 | $590 | $20 |
| Exam of the internal drainage system of eye | 17 | $397 | $21 |
2014: 8 services
| Return visit (30+ min) | 138 | $14,262 | $79 |
| Short return visit (20+ min) | 125 | $11,099 | $55 |
| New patient visit (45+ min) | 43 | $5,182 | $121 |
| Exam of visual field with extended testing | 49 | $2,894 | $55 |
| Removal of eyelashes using forceps | 17 | $1,420 | $35 |
| Established patient complete exam of visual system | 13 | $1,274 | $98 |
| Examination of eye by ophthalmoscope with retinal drawing | 30 | $751 | $21 |
| Exam of the internal drainage system of eye | 18 | $367 | $20 |
2013: 6 services
| Return visit (30+ min) | 158 | $13,477 | $71 |
| Short return visit (20+ min) | 121 | $9,977 | $55 |
| Removal of eyelashes using forceps | 30 | $2,832 | $35 |
| Exam of visual field with extended testing | 45 | $2,545 | $57 |
| New patient visit (45+ min) | 20 | $2,054 | $103 |
| Examination of eye by ophthalmoscope with retinal drawing | 30 | $889 | $21 |
Drugs they prescribed that Part D paid
$27,078
Pharmacies billed $27,078 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 129) in 2024. At or below the middle of the specialty; the typical ophthalmology clinician is at 0%.
41 generic and 88 brand-name prescriptions · $27,078 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Cyclosporine | 27 | $14,584 | $540 |
| Lumigan | 15 | $3,530 | $235 |
| Timolol Maleate | 18 | $1,318 | $73 |
| Latanoprost | 31 | $361 | $12 |
Year by year
| 2024 | 129 | 26 | 0% (0) | 68% | $27,078 |
| 2023 | 253 | 45 | 0% (0) | 59% | $78,825 |
| 2022 | 339 | 50 | 0% (0) | 55% | $121,734 |
| 2021 | 335 | 51 | 0% (0) | 51% | $114,653 |
| 2020 | 393 | 53 | None | 58% | $132,103 |
| 2019 | 442 | 67 | 0% (0) | 57% | $118,111 |
| 2018 | 499 | 90 | 0% (0) | 68% | $128,841 |
| 2017 | 535 | 101 | 0% (0) | 73% | $121,110 |
| 2016 | 410 | 86 | 0% (0) | 71% | $85,614 |
| 2015 | 436 | 101 | 0% (0) | 72% | $76,614 |
| 2014 | 370 | 91 | None | 82% | $74,924 |
| 2013 | 428 | 108 | 0% (0) | 79% | $64,450 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 7 drugs
| Restasis | 38 | $36,856 | $970 |
| Cyclosporine | 24 | $14,530 | $605 |
| Lumigan | 37 | $12,902 | $349 |
| Travoprost | 20 | $3,221 | $161 |
| Timolol Maleate | 20 | $2,090 | $104 |
| Latanoprost | 60 | $928 | $15 |
| Dorzolamide-Timolol | 19 | $340 | $18 |
2022: 9 drugs
| Restasis | 69 | $69,310 | $1,004 |
| Lumigan | 42 | $23,881 | $569 |
| Alphagan P | 12 | $4,441 | $370 |
| Travoprost | 20 | $4,433 | $222 |
| Simbrinza | 18 | $3,595 | $200 |
| Timolol Maleate | 33 | $2,142 | $65 |
| Latanoprost | 78 | $1,078 | $14 |
| Dorzolamide-Timolol | 19 | $1,033 | $54 |
| Olopatadine | 11 | $930 | $85 |
2021: 8 drugs
| Restasis | 69 | $70,117 | $1,016 |
| Lumigan | 39 | $23,474 | $602 |
| Travoprost | 26 | $5,756 | $221 |
| Alphagan P | 15 | $3,934 | $262 |
| Timolol Maleate | 36 | $1,980 | $55 |
| Dorzolamide-Timolol | 15 | $1,774 | $118 |
| Latanoprost | 78 | $1,397 | $18 |
| Olopatadine | 20 | $634 | $32 |
2020: 9 drugs
| Restasis | 83 | $80,759 | $973 |
| Lumigan | 34 | $19,145 | $563 |
| Travoprost | 32 | $6,466 | $202 |
| Simbrinza | 28 | $4,994 | $178 |
| Travatan Z | 19 | $4,146 | $218 |
| Timolol Maleate | 42 | $2,068 | $49 |
| Latanoprost | 83 | $1,235 | $15 |
| Dorzolamide-Timolol | 16 | $1,047 | $65 |
| Erythromycin | 15 | $225 | $15 |
2019: 9 drugs
| Restasis | 80 | $65,839 | $823 |
| Lumigan | 55 | $20,834 | $379 |
| Travatan Z | 59 | $15,452 | $262 |
| Simbrinza | 16 | $2,698 | $169 |
| Olopatadine | 24 | $2,180 | $91 |
| Latanoprost | 99 | $1,851 | $19 |
| Timolol Maleate | 25 | $1,504 | $60 |
| Brimonidine | 11 | $417 | $38 |
| Erythromycin | 16 | $177 | $11 |
2018: 9 drugs
| Restasis | 103 | $74,426 | $723 |
| Travatan Z | 91 | $19,630 | $216 |
| Lumigan | 51 | $14,853 | $291 |
| Simbrinza | 20 | $3,315 | $166 |
| Olopatadine | 21 | $1,627 | $77 |
| Timolol Maleate | 46 | $1,523 | $33 |
| Latanoprost | 79 | $1,130 | $14 |
| Brimonidine | 16 | $898 | $56 |
| Dorzolamide | 11 | $202 | $18 |
2017: 7 drugs
| Restasis | 108 | $63,909 | $592 |
| Travatan Z | 142 | $27,233 | $192 |
| Lumigan | 54 | $13,975 | $259 |
| Combigan | 16 | $4,505 | $282 |
| Simbrinza | 21 | $2,995 | $143 |
| Latanoprost | 75 | $1,102 | $15 |
| Timolol Maleate | 43 | $791 | $18 |
2016: 6 drugs
| Restasis | 61 | $40,303 | $661 |
| Lumigan | 80 | $17,971 | $225 |
| Travatan Z | 78 | $15,438 | $198 |
| Brimonidine | 15 | $1,214 | $81 |
| Latanoprost | 68 | $843 | $12 |
| Timolol Maleate | 26 | $549 | $21 |
2015: 11 drugs
| Restasis | 66 | $34,200 | $518 |
| Lumigan | 82 | $15,677 | $191 |
| Travatan Z | 71 | $11,066 | $156 |
| Pataday | 20 | $4,306 | $215 |
| Lotemax | 12 | $2,201 | $183 |
| Brimonidine | 14 | $1,011 | $72 |
| Fluorometholone | 12 | $773 | $64 |
| Latanoprost | 63 | $695 | $11 |
| Erythromycin | 24 | $303 | $13 |
| Timolol Maleate | 11 | $277 | $25 |
| Dorzolamide | 11 | $254 | $23 |
2014: 7 drugs
| Restasis | 84 | $42,789 | $509 |
| Lumigan | 80 | $12,802 | $160 |
| Pataday | 39 | $6,196 | $159 |
| Lotemax | 30 | $4,601 | $153 |
| Travatan Z | 23 | $3,161 | $137 |
| Brimonidine | 11 | $886 | $81 |
| Latanoprost | 46 | $850 | $18 |
2013: 10 drugs
| Restasis | 70 | $26,110 | $373 |
| Lumigan | 71 | $10,603 | $149 |
| Pataday | 54 | $8,194 | $152 |
| Lotemax | 42 | $7,254 | $173 |
| Travatan Z | 41 | $4,715 | $115 |
| Azopt | 11 | $1,375 | $125 |
| Latanoprost | 38 | $891 | $23 |
| Brimonidine | 13 | $802 | $62 |
| Dorzolamide | 11 | $363 | $33 |
| Erythromycin | 21 | $326 | $16 |
Money from drug and device companies
$425 in 2025
| 2025 | 3 | 7 | None | $425 |
| 2024 | 4 | 8 | None | $366 |
| 2023 | 6 | 16 | None | $703 |
| 2022 | 6 | 20 | None | $500 |
| 2021 | 5 | 10 | None | $493 |
| 2020 | 1 | 1 | None | $24 |
| 2019 | 5 | 9 | None | $742 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Alcon Vision | Tryptyr | $317 | 5 payments
|
| Revance Therapeutics | Daxxify | $88 | 1 payment
|
| Abbvie | Botox | $20 | 1 payment
|
See all 7 published payments
| Alcon Vision | Meals · 2025-09-26 | Tryptyr | $24 |
| Alcon Vision | Meals · 2025-08-30 | Tryptyr | $8 |
| Alcon Vision | Meals · 2025-08-21 | Tryptyr | $126 |
| Alcon Vision | Meals · 2025-06-26 | Rocklatan | $125 |
| Abbvie | Meals · 2025-05-14 | Botox | $20 |
| Revance Therapeutics | Meals · 2025-05-13 | Daxxify | $88 |
| Alcon Vision | Meals · 2025-01-31 | Rocklatan | $33 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $366
| Bausch & Lomb Americas | Vyzulta | $125 | 1 payment
|
| Revance Therapeutics | Daxxify | $120 | 1 payment
|
| Biotissue Holdings | None | $82 | 4 payments
|
| Alcon Vision | Eysuvis | $39 | 2 payments
|
2023: $703
| Carl Zeiss Meditec USA | Visumax | $197 | 3 payments
|
| Biotissue Holdings | Prokera | $174 | 2 payments
|
| Alcon Vision | Eysuvis | $168 | 3 payments
|
| Oyster Point Pharma | Tyrvaya | $103 | 5 payments
|
| Bausch & Lomb Americas | Vyzulta | $40 | 2 payments
|
| Sun Pharmaceutical Industries | Cequa | $20 | 1 payment
|
2022: $500
| Sun Pharmaceutical Industries | Cequa | $148 | 4 payments
|
| Oyster Point Pharma | Tyrvaya | $124 | 8 payments
|
| Carl Zeiss Meditec USA | Visumax | $92 | 2 payments
|
| Kala Pharmaceuticals | Inveltys | $62 | 3 payments
|
| Novartis Pharmaceuticals | Xiidra | $40 | 2 payments
|
| BioTissue Holdings | Prokera | $34 | 1 payment
|
2021: $493
| Carl Zeiss Meditec USA | Visumax | $228 | 3 payments
|
| Allergan | None | $125 | 1 payment
|
| Kala Pharmaceuticals | Inveltys | $72 | 3 payments
|
| Novartis Pharmaceuticals | Xiidra | $47 | 2 payments
|
| Sun Pharmaceutical Industries | Cequa | $21 | 1 payment
|
2020: $24
| Novartis Pharmaceuticals | Xiidra | $24 | 1 payment
|
2019: $742
| Carl Zeiss Meditec | Visumax | $410 | 4 payments
|
| Shire North American Group | Xiidra | $125 | 1 payment
|
| Alexion Pharmaceuticals | Soliris | $125 | 1 payment
|
| Johnson & Johnson Surgical Vision | None | $58 | 2 payments
|
| Alcon Vision | Acrysof | $25 | 1 payment
|
Professional record
- NPI
- 1841208352
- Licence
- CA G77619California G77619: Current · expires 2027-01-31
More record details
- Sole proprietor
- Yes
- Medicaid ID
- CA 00G776190
- Taxonomy
- Federal specialty code 207W00000X (207W00000X)
- Mailing address
- 20269 Stevens Creek Blvd, Cupertino, CA, 95014
- NPI first listed
- 2006-08-03
- NPI last updated
- 2015-07-30
This is when the NPI record was last certified, not a medical board exam.